Moderna (NASDAQ:MRNA) has outperformed the market over the past 5 years by 42.19% on an annualized basis producing an average annual return of 54.8%. Currently, Moderna has a market capitalization of $45.66 billion.
Buying $1000 In MRNA: If an investor had bought $1000 of MRNA stock 5 years ago, it would be worth $8,701.97 today based on a price of $119.13 for MRNA at the time of writing.
Moderna's Performance Over Last 5 Years
![bigjpg](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20240725/0-31e30da4a41de250168eb8cbc07fea8c-0-22b09a62915b8af282c85db63d0120af.webp/bigjpg)
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.